Dengue: a continuing global threat
Open accessThe DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Abstract
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Until recent advances in vaccine development [16–17], and the approval and potential availability of the first product in 2016 [18], dengue has been unique among the major vector-borne diseases, in that prevention from infection could only be attempted by reducing or eliminating bites by infected vector mosquitoes [19, 20].”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although a vaccine could be available as early as 2016, vector control remains the primary approach used to prevent dengue, the most common and widespread arbovirus of humans worldwide.”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dengue and Dengue Hemorrhagic Fever
Gubler, D. J. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.480 · Cited by 4,310
Self-citationLanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J., & Vorndam, A. V. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.545-551.1992 · Cited by 1,818 · cited 1×
“The most E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s commonly used NAATs are based on a single RT-PCR assay 95,96 , a nested RT-PCR assay 96 or a one-step multiplex RT-PCR assay 97 .”
MethodSelf-citationDengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632 · cited 1×
“One advantage of this assay is the ability to determine viral titre early in dengue illness, which is believed to be an important predictor of disease severity 102 .”
BackgroundGuzmán, M. G., & Kouri, G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00171-2 · Cited by 1,163
Spectrum of Disease and Relation to Place of Exposure among Ill Returned Travelers
Freedman, D. O., Weld, L. H., Kozarsky, P. E., Fisk, T., Robins, R., von Sonnenburg, F., Keystone, J. S., Pandey, P., & Cetron, M. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051331 · Cited by 1,081
Dengue and dengue haemorrhagic fever
Rigau-Pérez, J. G., Clark, G. G., Gubler, D. J., Reiter, P., Sanders, E. J., & Vance Vorndam, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12483-7 · Cited by 1,051
Self-citationCross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943 · cited 1×
“The available data suggest that neutralizing antibodies are the major contributors to protective immunity 124,125 , however the role of the cellular immune response requires further study 123 .”
BackgroundCalisher, C. H., Karabatsos, N., Dalrymple, J. M., Shope, R. E., Porterfield, J. S., Westaway, E. G., & Brandt, W. E. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-37 · Cited by 893 · cited 1×
“These tests are mainly for research and vaccine studies 90–94 .”
BackgroundOriginal antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
Mongkolsapaya, J., Dejnirattisai, W., Xu, X.-N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivorn, S., Duangchinda, T., Dong, T., Rowland-Jones, S., et al. (2003) · Nature Medicine · doi:10.1038/nm887 · Cited by 821 · cited 1×
“…CD4 + and CD8 + cells that have a diminished capacity to kill but nonetheless release inflammatory cytokines that contribute to disease severity 51 ; that severe disease is caused by DENVs of increased virulence 52 ; and the suggestion that cross-reactivity between NS1 and human platelets and…”
BackgroundDengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 804 · cited 5×
“Both in vitro and in vivo , macrophages and monocytes participate in antibody-dependent enhancement (ADE) 18–20 .”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 3
- Vorndam, V. & Kuno, G. In Dengue and Dengue Hemorrhagic Fever (eds Gubler, D. J. & Kuno, G.) 313–333 (CAB International, New York, USA, 1997).
- Gubler, D. J. Serologic diagnosis of dengue/dengue haemorrhagic fever. Dengue Bull. 20, 20–23 (1996).
- Singh, K. R. P. & Paul, S. D. Multiplication of arboviruses in cell lines from Aedes albopictus and Aedes aegypti. Curr. Sci. 37, 65–67 (1968).
Cited by
Items 901–1,000 of 1,001
Dengue vaccines: Are they safe for travelers?
Halstead, S. B., & Aguiar, M. (2016) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2016.06.005 · Cited by 18
Self-citationA Quinoline Compound Inhibits the Replication of Dengue virus Serotypes 1–4 in Vero Cells
Beesetti, H., Tyagi, P., Medapi, B., Krishna, V. S., Sriram, D., Khanna, N., & Swaminathan, S. (2017) · Antiviral Therapy · doi:10.3851/imp3231 · Cited by 18
“Ideally, prophylactic and therapeutic agents must target all four DENVs as they co-circulate in hyperendemic regions and each is capable of causing the full spectrum of dengue disease [4,5].”
BackgroundZwick, C. R., & Renata, H. (2018) · Tetrahedron · doi:10.1016/j.tet.2018.09.046 · Cited by 18
Adu, B., Issahaque, Q.-A., Sarkodie-Addo, T., Kumordjie, S., Baafour, E. K., Sinclear, C. K., Eyia-Ampah, S., Owusu-Yeboa, E., Theisen, M., & Dodoo, D. (2020) · Infection and Immunity · doi:10.1128/iai.00125-20 · Cited by 24
“replaced by IgG during infections (42, 43).”
Review of -omics studies on mosquito-borne viruses of the Flavivirus genus
Peinado, R. D. S., Eberle, R. J., Pacca, C. C., Arni, R. K., & Coronado, M. A. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198610 · Cited by 19
Yen, T., dos Santos, M. D. J. T., Tseng, L.-F., Chang, S.-F., Cheng, C.-F., Carvalho, A. V. D. A., Shu, P., Lien, J. C., & Tsai, K. (2015) · Acta Tropica · doi:10.1016/j.actatropica.2015.12.012 · Cited by 19
Nguyen, N.-L., So, K.-K., Kim, J.-M., Kim, S., Jang, Y., Yang, M., & Kim, D. (2014) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2014.06.005 · Cited by 19
Sharma, K. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/14285.6710 · Cited by 18
Jiang, L., & Sun, Q. (2018) · Virology Journal · doi:10.1186/s12985-018-0963-1 · Cited by 18
Dengue modeling in rural Cambodia: Statistical performance versus epidemiological relevance
Champagne, C., Paul, R. E. L., Ly, S., Duong, V., Leang, R., & Cazelles, B. (2018) · Epidemics · doi:10.1016/j.epidem.2018.08.004 · Cited by 21
Dengue: A reemerging concern for travelers
Hynes, N. A. (2012) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.79a.11048 · Cited by 22
“52 During primary infection, viremia and antigenemia usually parallel fever, but when a person is later infected with a different dengue serotype, the period of viremia may be as short as 2 to 3 days, with antigens persisting in the serum for several more days.”
BackgroundGeleta, E. N. (2019) · Research and Reports in Tropical Medicine · doi:10.2147/rrtm.s218586 · Cited by 17
“infection can usually be detected after the first 5–7 days of infection.(30,31) However, the possibility that as the IgM antibodies remain negative for the first few days, and also the IgM reactivity was non-specific; thus, there is crossreactive due to infection with another flavivirus.”
BackgroundBuijsers, B., Garishah, F. M., Riswari, S. F., van Ast, R. M., Pramudo, S. G., Tunjungputri, R. N., Overheul, G. J., van Rij, R. P., van der Ven, A. J. A. M., Alisjahbana, B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.759570 · Cited by 17
“Heparanase (HPSE) (12, 13) is the only known human endob (1-4)-D-glucuronidase that is able to degrade HS within the endothelial glycocalyx (14).”
BackgroundNana-Ndjangwo, S. M., Djiappi-Tchamen, B., Mony, R., Demanou, M., Keumezeu-Tsafack, J., Bamou, R., Awono‐Ambene, P., Bilong, C. F. B., & Antonio‐Nkondjio, C. (2022) · Viruses · doi:10.3390/v14102127 · Cited by 17
“Dengue and chikungunya are caused by viruses (DENV and CHIKV) belonging to different families (Flaviviridae and Togaviridae, respectively) [2,14].”
BackgroundDuong, C. V., Kang, J. H., Nguyen, V. V., & Bae, Y. J. (2022) · Insects · doi:10.3390/insects13121079 · Cited by 18
Wei, C., Zong, K., Li, W., Zhao, X., Ruan, J., Zhang, S., Li, J., Liu, X., Yan, H., Cao, R., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141328 · Cited by 17
Ansari, A., Sachan, S., Ahuja, J., Sureshkumar, V., Nikam, B., Kumar, V., Jain, S., Singh, B. P., Coshic, P., Sikka, K., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115366 · Cited by 19
Ranzoni, A., den Hamer, A., Karoli, T., Buechler, J. A., & Cooper, M. A. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00762 · Cited by 17
Niyomrattanakit, P., Wan, K. F., Chung, K. Y., Abas, S. N., Seh, C. C., Dong, H., Lim, C. C., Chao, A. T., Lee, C. B., Nilar, S., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.04.007 · Cited by 17
“No specific anti-viral therapy is available for treatment of DENV infections that affect a large number of the world population (Guzman et al., 2010; Halstead, 2002; Gubler, 1998).”
BackgroundEvolutionary history and spatiotemporal dynamics of dengue virus type 1 in Asia
Sun, Y., & Meng, S. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2013.01.013 · Cited by 17
Khedr, A., Hegazy, M. A. M., Kamal, A., & Shehata, M. A.-A. (2014) · Journal of Separation Science · doi:10.1002/jssc.201400749 · Cited by 17
Daudé, É., Vaguet, A., & Paul, R. E. L. (2015) · Natures Sciences Sociétés · doi:10.1051/nss/2015058 · Cited by 28
“La dengue, maladie à transmission vectorielle, est devenue une préoccupation majeure de santé publique internationale (Guzman et al. , 2010).”
Acute liver failure in dengue haemorrhagic fever
Arora, S., Devakiruba, N. S., Paul, J. C., & Hansdak, S. G. (2015) · BMJ Case Reports · doi:10.1136/bcr-2015-209443 · Cited by 17
Review of Current Dengue Treatment and Therapeutics in Development
RT, F. D. C. (2014) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.s8-002 · Cited by 19
“DENV is an arthropod-borne flavivirus associated with both hemorrhagic fever and hemorrhagic shock [4].”
BackgroundCost-Effectiveness of the Strategies to Reduce the Incidence of Dengue in Colima, México
Mendoza‐Cano, O., Hernández-Suárez, C., Trujillo, X., Ochoa‐Díaz‐López, H., Lugo-Radillo, A., Espinoza‐Gómez, F., Ruiz, M. D. L. C., Sánchez-Piña, R. A., & Murillo‐Zamora, E. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14080890 · Cited by 18
“Currently, there is not an approved dengue vaccine and the prevention of this viral disease is focused on the reduction of bites by infected mosquitoes [5].”
BackgroundBatool, K., Alam, I., Wu, S., Liu, W., Zhao, G., Chen, M., Wang, J., Xu, J., Huang, T., Pan, X., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30741-x · Cited by 24
Dengue in parts of the Guinea Savannah region of Nigeria and the risk of increased transmission
Omatola, C. A., Onoja, A. B., Moses, E. A., Mahmud, M., & Mofolorunsho, K. C. (2020) · International Health · doi:10.1093/inthealth/ihaa033 · Cited by 17
Kuo, Y.-T., Liu, C., Li, J.-W., Lin, C., Jassey, A., Wu, H., Perng, G., Yen, M., & Lin, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-71849-3 · Cited by 17
Assessment of Urban Land Surface Temperature and Vertical City Associated with Dengue Incidences
Nakhapakorn, K., Sancharoen, W., Mutchimwong, A., Jirakajohnkool, S., Onchang, R., Rotejanaprasert, C., Tantrakarnapa, K., & Paul, R. E. L. (2020) · Remote Sensing · doi:10.3390/rs12223802 · Cited by 19
de Fabritus, L., Nougaırède, A., Aubry, F., Gould, E. A., & de Lamballerie, X. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159564 · Cited by 18
Songprakhon, P., Limjindaporn, T., Perng, G., Puttikhunt, C., Thaingtamtanha, T., Dechtawewat, T., Saitornuang, S., Uthaipibull, C., Thongsima, S., Yenchitsomanus, P.-T., et al. (2018) · Journal of General Virology · doi:10.1099/jgv.0.001134 · Cited by 18
Aguiar, M., Steindorf, V., Srivastav, A. K., Stollenwerk, N., & Kooi, B. W. (2024) · Nonlinear Dynamics · doi:10.1007/s11071-024-09710-9 · Cited by 16
“Whenthe temporary cross-protection fades, patients who experience a secondary heterologous dengue virus infection faceanincreasedriskofseveredisease,primarilydueto the Antibody-Dependent Enhancement process (ADE) [9,16,19,29].”
Recent Advances in Dengue: Relevance to Puerto Rico.
Noyd, D. H., & Sharp, T. M. (2015) · PubMed · Cited by 16
Borges, G. R., Aboelkheir, M. G., de Souza, F. G., Waldhelm, K. C., & Kuster, R. M. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-08679-3 · Cited by 16
Circulation du virus de la dengue en Afrique de l’Ouest
Tinto, B., Kania, D., Kagone, T., Dicko, A., Traore, I. T., de Rekeneire, N., Bicaba, B. W., Hien, H., de Perre, P. V., Simonin, Y., et al. (2022) · médecine/sciences · doi:10.1051/medsci/2022007 · Cited by 16
Lue, A. M., Richards-Dawson, M.-A., Gordon-Strachan, G. M., Kodilinye, S. M., Dunkley-Thompson, J., James-Powell, T., Pryce, C. A., Mears, C. D., Anzinger, J. J., Webster‐Kerr, K., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.889998 · Cited by 16
“Children typically have the most severe presentations of dengue and the highest attributable-morbidity and mortality (7).”
BackgroundHaq, F. U., Imran, M., Aslam, Z., Mukhtar, F., Jabeen, K., Chaudhry, M., Rahman, S. U., & Muhammad, N. (2023) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.23-0309 · Cited by 16
Poungou, N., Sevidzem, S. L., Koumba, A. A., Koumba, C. R. Z., Mbehang, P., Onanga, R., Zahouli, J. Z. B., Maganga, G. D., Djogbénou, L., Borrmann, S., et al. (2023) · Microorganisms · doi:10.3390/microorganisms12010004 · Cited by 19
“It should be noted that Cameroon has a national YFV surveillance system that is planned and implemented by the expanded programme on immunization (EPI) of the Ministry of Public Health, with support from foreign donors.”
BackgroundResistance analysis of an antibody that selectively inhibits dengue virus serotype-1
Zou, G., Kukkaro, P., Lok, S., Ng, J. K. W., Tan, G. K., Hanson, B. J., Alonso, S., MacAry, P. A., & Shi, P. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.06.010 · Cited by 16
“5 billion people are at risk of DENV infection worldwide (Gubler et al., 2007; Guzman et al., 2010).”
BackgroundInfluentialYohan, B., Kendarsari, R. I., Mutia, K., Bowolaksono, A., Harahap, A. R., & Sasmono, R. T. (2014) · Acta Virologica · doi:10.4149/av_2014_01_20 · Cited by 18
“5 billion population living in areas with potential risk for dengue (Guzman et al., 2010; Simmons et al., 2012).”
BackgroundInfluentialChen, H., Gao, N., Wu, J., Zheng, X., Li, J., Fan, D., & An, J. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.08.005 · Cited by 16
Xu, B., Lee, E. M., Medina, A., Sun, X., Wang, D., Tang, H., & Zhou, G. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104205 · Cited by 16
Zheng, B., Wang, H., Cui, G., Guo, Q., Si, L., Yan, H., Fang, D., Jiang, L., Jiang, Z., & Zhou, J. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00477 · Cited by 16
Halton, K. A., Sarna, M. K., Barnett, A. G., Leonardo, L., & Graves, N. (2013) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/01938924-201311020-00001 · Cited by 26
Dengue Virus Entry and Trafficking: Perspectives as Antiviral Target for Prevention and Therapy
Castilla, V., Piccini, L. E., & Damonte, E. B. (2015) · Future Virology · doi:10.2217/fvl.15.35 · Cited by 16
Keelapang, P., Nitatpattana, N., Suphatrakul, A., Punyahathaikul, S., Sriburi, R., Pulmanausahakul, R., Pichyangkul, S., Malasit, P., Yoksan, S., & Sittisombut, N. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.027 · Cited by 16
Self-citationSuwanbamrung, C. (2012) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(12)60100-5 · Cited by 16
“5 billion people are at risk of infection, approximately 975 million of whom live in urban and rural areas in tropical and sub-tropical countries[1].”
BackgroundComplete Genome Sequence of a Dengue Virus Serotype 4 Strain Isolated in Roraima, Brazil
Naveca, F. G., de Souza, V. C., Silva, G., Maito, R. M., Granja, F., Siqueira, T. C. D. S., & Acosta, P. O. A. (2012) · Journal of Virology · doi:10.1128/jvi.06731-11 · Cited by 16
“Dengue virus (DENV) infections are the most important cause of arthropod-borne viral diseases worldwide (7).”
BackgroundSivan, A., Shriram, A. N., Sugunan, A. P., Maile, A., Muruganandam, N., Kartick, C., & Vijayachari, P. (2016) · Acta Tropica · doi:10.1016/j.actatropica.2016.01.015 · Cited by 16
Gupta, B. P., Lamsal, M., Chaulagain, S., Rauniyar, R., Malla, R., Shrestha, S., Kurmi, R., & Manandhar, K. D. (2018) · VirusDisease · doi:10.1007/s13337-018-0439-3 · Cited by 16
“uncontrolled population growth, ineffective vector control, global warming as well as inadequate public health facilities [16].”
BackgroundAssociation between MBL2 haplotypes and dengue severity in children from Rio de Janeiro, Brazil
Ornelas, A. M. D. M., de Carvalho, C. X., Alvarado-Arnez, L. E., Alves, M. R., Rossi, Á. D., Tanuri, A., Aguiar, R. S., Moraes, M. O., & Cardoso, C. C. (2019) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760190004 · Cited by 16
“(3) In Americas, The Southern Cone subregion reported a total of 254,453 dengue cases in 2017 from which, 99% were reported in Brazil.”
BackgroundDefeat Dengue and Zika Viruses With a One-Two Punch of Vaccine and Vector Blockade
Sun, J., Du, S., Zheng, Z., Cheng, G., & Jin, X. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00362 · Cited by 17
Thirty Years after the Cuban Hemorrhagic Dengue Epidemic of 1981
Guzmán, M. G. (2012) · MEDICC Review · doi:10.37757/mr2012v14.n2.11 · Cited by 17
The 2023 Dengue Outbreak in Bangladesh: An Epidemiological Update
Hossain, M., Rakib, M. S. I., Hasan, M. M., Powshi, S. N., Islam, E., & Islam, N. N. (2025) · Health Science Reports · doi:10.1002/hsr2.70852 · Cited by 15
Flavivirus Pathogenesis in the Mosquito Transmission Vector
Troupin, A., Grippin, C., & Colpitts, T. M. (2017) · Current Clinical Microbiology Reports · doi:10.1007/s40588-017-0066-6 · Cited by 15
de Oliveira, C. C. D. S., & Neto, P. D. O. P. D. L. (2024) · Revista JRG de Estudos Acadêmicos · doi:10.55892/jrg.v7i14.951 · Cited by 15
Hossain, M. S., Hasnat, S., Akter, S., Mim, M. M., Tahcin, A., Hoque, M., Sutradhar, D., Keya, M. A. A., Sium, N. R., Hossain, S., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1465827 · Cited by 15
Climate, inter-serotype competition and arboviral interactions shape dengue dynamics in Thailand
Perez, L. J., Yamaguchi, J., Weiss, S. L., Carlos, C. E. S. E. D. M., Meyer, T. V., Rodgers, M. A., Phoompoung, P., Suputtamongkol, Y., Cloherty, G., & Berg, M. G. (2025) · Communications Biology · doi:10.1038/s42003-025-07999-9 · Cited by 15
Lessons raised by the major 2010 dengue epidemics in the French West Indies
Larrieu, S., Cassadou, S., Rosine, J., Chappert, J. L., Blateau, A., Ledrans, M., & Quénel, P. (2013) · Acta Tropica · doi:10.1016/j.actatropica.2013.11.023 · Cited by 17
The Potential Impact of Vaccination on the Dynamics of Dengue Infections
Knipl, D., & Moghadas, S. M. (2015) · Bulletin of Mathematical Biology · doi:10.1007/s11538-015-0120-6 · Cited by 15
Dengue virus surveillance: Detection of DENV-4 in the city of São José do Rio Preto, SP, Brazil
Colombo, T. E., Vedovello, D., Pacca, C. C., Mondini, A., Araújo, J. P., Cabrera, E. M. S., Lopes, J. C., dos Santos, I. N. P., Reis, A. F. N., Costa, F. R., et al. (2016) · Acta Tropica · doi:10.1016/j.actatropica.2016.09.004 · Cited by 15
Bone breaking infections – A focus on bacterial and mosquito-borne viral infections
Cui, Y. C., Wu, Q., Teh, S. W., Peli, A., Bu, G., Qiu, Y., Benelli, G., & Kumar, S. S. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.06.021 · Cited by 15
de Souza, R. S., Gama, M. D. V. F., Schama, R., Lima, J. B. P., Diaz-Albiter, H. M., & Genta, F. A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00122 · Cited by 15
“6) have conserved glutamate residues within the consensus region SGE(I/V)DL(M/L)ES(R/K), acting as donors and proton acceptors for the enzymatic activity of β-1,3-glucanases (Hahn et al., 1995), while such residues were absent in the AeGH16.”
BackgroundIkhtiarudin, I. (2019) · INDONESIAN JOURNAL OF PHARMACY · doi:10.14499/indonesianjpharm30iss2pp84-90 · Cited by 15
Noleto, J. V. O., Morais, H. L. M. D. N., Lima, T. D. M., Rodrigues, J. G. M., Cardoso, D. T., Lima, K. C., Melo, R. S. D. S., & Miranda, G. S. (2020) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.12245 · Cited by 15
“control are therefore still the best ways of preventing potential outbreaks [8-10].”
BackgroundDengue Outbreak is a Global Recurrent Crisis: Review of the Literature
Araf, Y., Ullah, M. A., Faruqui, N. A., Mowna, S. A., Prium, D. H., & Sarkar, B. (2020) · Electronic Journal of General Medicine · doi:10.29333/ejgm/8948 · Cited by 16
Laboratory Diagnosis of Dengue: A Review
Shamala, D. S. (2015) · IIUM Medical Journal Malaysia · doi:10.31436/imjm.v14i1.452 · Cited by 15
Zhao, T., Li, B., Gao, H., Xing, D., Li, M.-J., Dang, Y.-Q., Zhang, H., Zhao, Y., Liu, Z., & Li, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.891151 · Cited by 15
Dengue encephalitis featuring “double-doughnut” sign - A case report
Pandeya, A., Upadhyay, D., Oli, B., Parajuli, M., Silwal, N., Shrestha, A., Gautam, N., & Gajurel, B. P. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103939 · Cited by 15
An ensemble forecast system for tracking dynamics of dengue outbreaks and its validation in China
Chen, Y., Liu, T., Yu, X., Zeng, Q., Cai, Z., Wu, H., Zhang, Q., Xiao, J., Ma, W., Pei, S., et al. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010218 · Cited by 15
“More than 390 million people are infected with dengue every year [2,3].”
BackgroundMathematical analysis of the impact of community ignorance on the population dynamics of dengue
Aldila, D., Puspadani, C. A., & Rusin, R. (2023) · Frontiers in Applied Mathematics and Statistics · doi:10.3389/fams.2023.1094971 · Cited by 15
Moi, M. L., Takasaki, T., Saijo, M., & Kurane, I. (2013) · Archives of Virology · doi:10.1007/s00705-013-1787-3 · Cited by 15
“In particular, the possibility that dengue-vaccine-induced ADE might potentially increase the risk of severe dengue illness has been a concern in vaccine development [13–15].”
BackgroundTsai, W.-Y., Hsieh, S., Lai, C.-Y., Lin, H.-E., Nerurkar, V. R., & Wang, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052600 · Cited by 15
Investigation of the Cry4B–Prohibitin Interaction in Aedes aegypti Cells
Kuadkitkan, A., Smith, D. R., & Berry, C. (2012) · Current Microbiology · doi:10.1007/s00284-012-0178-4 · Cited by 15
Anti-infective vaccination in the 21st century—new horizons for personal and public health
Scully, I. L., Swanson, K. A., Green, L., Jansen, K. U., & Anderson, A. S. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.07.006 · Cited by 15
Yee, D. A., Ezeakacha, N. F., & Abbott, K. C. (2016) · Oikos · doi:10.1111/oik.03635 · Cited by 18
Ahamed, S. F., Vivek, R., Kotabagi, S., Nayak, K., Chandele, A., Murali‐Krishna, K., & Shet, A. (2017) · Journal of Virological Methods · doi:10.1016/j.jviromet.2017.02.014 · Cited by 15
Faria, N. R. D. C., Solórzano, V. F., de Souza, L. J., Nogueira, R. M. R., de Bruycker‐Nogueira, F., Chouin-Carneiro, T., Simões, J. B. S., Lima, M. D. R. Q., Pinto, L. M. D. O., Kubelka, C. F., et al. (2017) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0227 · Cited by 15
Azami, N. A. M., Moi, M. L., Ami, Y., Suzaki, Y., Lim, C., Taniguchi, S., Saijo, M., Takasaki, T., & Kurane, I. (2018) · Virology Journal · doi:10.1186/s12985-018-0967-x · Cited by 15
“Dengue (DEN) is a major public health threat in tropical and subtropical regions, including Southeast Asia, the South Pacific, the Eastern Mediterranean, and the Americas [1, 2].”
Dengue rapid diagnostic tests: Health professionals’ practices and challenges in Burkina Faso
Zongo, S., Carabalí, M., Muñoz, M. J. R., & Ridde, V. (2018) · SAGE Open Medicine · doi:10.1177/2050312118794589 · Cited by 15
Concurrent infections of dengue virus serotypes in Bali, Indonesia
Masyeni, S., Yohan, B., & Sasmono, R. T. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4164-9 · Cited by 15
Cunha, M. D. P., Duarte‐Neto, A. N., Pour, S. Z., Hajjar, L. A., Frassetto, F. P., Dolhnikoff, M., Saldiva, P. H. N., & Zanotto, P. M. D. A. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05959-2 · Cited by 15
“DENV are arthropod-borne viruses associated with Aedes vectors [2], belong to the genus Flavivirus (family Flaviviridae) [3, 4], and are classified in four phylogenetically and antigenically distinct serotypes (DENV-1-4) that cause outbreaks in humans and are also established sylvatic cycle infecting nonhuman primates.”
BackgroundA NEW POSSIBILITY FOR SURVEILLANCE: DO WE IDENTIFY ALL CASES OF LEPTOSPIROSIS?
Fontes, R. M., Cavalcanti, L. P. D. G., Oliveira, A. C. A., Bezerra, L. F. D. M., Gomes, A. M. M., Colares, J. K. B., & Lima, D. M. (2015) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652015000500014 · Cited by 15
Wijayanti, S. P. M., Anandari, D., & Maghfiroh, A. F. A. (2017) · Kesmas Indonesia · doi:10.20884/1.ki.2017.9.01.228 · Cited by 15
ARF4-mediated intracellular transport as a broad-spectrum antiviral target
Li, M., Deng, K., Cheng, X.-H., Siu, L. Y.-L., Gao, Z.-R., Naik, T. S., Stancheva, V. G., Cheung, P. P., Teo, Q. W., van Leur, S. W., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-01940-w · Cited by 18
Mathematical modeling in perspective of vector-borne viral infections: a review
Prasad, R., Sagar, S. K., Parveen, S., & Dohare, R. (2022) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-022-00282-4 · Cited by 19
“In 2010, the continuous global threat of dengue was presented in [42], concluding that the control measures like antiviral vaccines and drugs should be developed, which will make an important contribution to the upcoming dengue outbreak.”
BackgroundNeurological Manifestations of Perinatal Dengue
Maheshwari, A., Singh, S., Amrit, A., Alallah, J., & Boppana, S. B. (2023) · Newborn · doi:10.5005/jp-journals-11002-0066 · Cited by 21
Within-host models unravelling the dynamics of dengue reinfections
Anam, V., Guerrero, B. V., Srivastav, A. K., Stollenwerk, N., & Aguiar, M. (2024) · Infectious Disease Modelling · doi:10.1016/j.idm.2024.02.004 · Cited by 14
“There is, however, good evidence that sequential infection with a different serotype (heterologous infection) increases the risk of developing severe disease due to a process described as antibody-dependent en-48 hancement (ADE) [4, 5, 6, 7].”
BackgroundSaha, O., Razzak, A., Sarker, N., Rahman, N., bin Zahid, A., Sultana, A., Shishir, T. A., Bahadur, N. M., Rahaman, M. M., Hossen, F., et al. (2024) · Discover Applied Sciences · doi:10.1007/s42452-024-05782-9 · Cited by 16
“Cross-reactive antibodies generated by previous exposure to different DENV serotypes or related flaviviruses, such as Zika and yellow fever, can trigger this complex phenomenon [18, 19].”
Rob, M. A., Hossain, M., Sattar, M. A., Ahmed, I. U., Chowdhury, A. F. M. N., Mehedi, H. M. H., Mohammed, N., Quader, M. M. U., Hossain, M. Z., Rahman, M., et al. (2024) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2024.00069 · Cited by 14
“The four structurally similar but anti-genically distinct dengue virus (DENV) serotypes (DENV1-DENV4) have been found to be circulating in various types of population [3, 4].”
BackgroundProgress and challenges in development of animal models for dengue virus infection
Wang, Y., Yuansong, Y., Susu, L., Chen, L., Wu, Y., Yining, W., Wang, Y., & Chang-fa, F. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2404159 · Cited by 14
“The Dengue outbreak, caused by the dengue virus (DENV), is considered one of the most significant arthropod-borne viral infections affecting human populations in various tropical and subtropical regions [1].”
BackgroundGayatri, A. P., Bandaru, N., Bonthu, M. G., & Tandu, D. S. (2025) · Current Biotechnology · doi:10.2174/0122115501356874250311074358 · Cited by 17
Diagnostic Efficacy of Saliva For Dengue - A Reality in Near Future? A Piloting Initiative
Banavar, S. R. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/7521.4169 · Cited by 14
“Dengue is endemic or epidemic in almost every country which is located in the tropics [3].”
BackgroundInfluentialEVALUATION OF A COMMERCIAL RAPID TEST KIT FOR DETECTION OF ACUTE DENGUE INFECTION.
Krishnananthasivam, S., Fernando, A. N., Tippalagama, R., Tennekoon, R. N., Man, J. D., Seneviratne, D., Premawansa, S., Premawansa, G., & Ad, D. S. (2015) · PubMed · Cited by 14
Early dengue virus interactions: the role of dendritic cells during infection
Souza, H. F. S., Almeida, B. D. S., & Boscardin, S. B. (2016) · Virus Research · doi:10.1016/j.virusres.2016.07.001 · Cited by 16
Economic report on the cost of dengue fever in Vietnam: case of a provincial hospital
Pham, L. D., Nhat, P. T. H., Le, N. D. T., & Vo, T. Q. (2016) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s124023 · Cited by 14
“Sequential heterotypic infections are also common in dengue-endemic areas.(7) Not until 1970 had nine countries undergone dengue epidemics.”
Serodiagnosis of dengue virus infection using commercially available antibody and NS1 antigen ELISAs
Granger, D., Leo, Y. S., Lee, L. Y. K., & Theel, E. S. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.03.015 · Cited by 14
Prado, P. S., Júnior, J. T. D. A., de Abreu, L. T., Silva, C. G., Souza, L. D. C., Gomes, M. C., Mendes, L. M. T., dos Santos, E. M., & Romero, G. A. S. (2018) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760170433 · Cited by 14
“Consequently, the accurate and reliable diagnosis is of great interest for clinical management and avoiding disease progression towards severe manifestations (Guzmán et al. 2010).”
BackgroundUsing bioinformatics tools for the discovery of Dengue RNA-dependent RNA polymerase inhibitors
Ncube, N. B., Ramharack, P., & Soliman, M. E. S. (2018) · PeerJ · doi:10.7717/peerj.5068 · Cited by 14
Abeysuriya, V., Choong, C. S. H., Thilakawardana, B. U., de Mel, P., Shalindi, M., de Mel, C., Chandrasena, L. G., Seneviratne, S. L., Yip, C. Y. C., Yap, E. S., et al. (2019) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trz128 · Cited by 14
Metadata
- Authors
- Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., Nathan, M. B., Pelegrino, J. L., Simmons, C., Yoksan, S., & Peeling, R. W.
- Affiliations
- Public Health Agency of Canada (CA)
- Institut Pasteur du Cambodge (KH)
- Oxford University Clinical Research Unit (VN)
- National University of Singapore (SG)
- Centers for Disease Control and Prevention (US)
- World Bank (US)
- Instituto de Medicina Tropical “Pedro Kourí” (CU)
- World Health Organization (CH)
- Mahidol University (TH)
- Corresponding author
- Peeling, Rosanna W.
- ORCID
- Venue
- Nature Reviews Microbiology
- Published
- 2010-12
- Volume
- 8
- Issue
- S12
- Pages
- S7-S16
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC4333201
- OpenAlex
- W2042479028
- Cited by
- 2,082
- References
- 130
- Citations by year
- 2026: 68 · 2025: 104 · 2024: 94 · 2023: 135 · 2022: 116 · 2021: 133 · 2020: 140 · 2019: 127 · 2018: 142 · 2017: 151 · 2016: 163 · 2015: 189 · 2014: 186 · 2013: 161 · 2012: 132
- FWCI
- 15.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- Wellcome Trust (084368)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Dengue and Mosquito Control Research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Keywords
- dengue, dengue hemorrhagic fever, arboviruses, dengue serotypes, vector-borne diseases, dengue surveillance, outbreak response, integrated vector management, early diagnosis, dengue vaccine, antiviral agents, dengue control
- MeSH terms
- Americas, Asia, Southeastern, Dengue, Dengue Virus, Hospitalization, Humans, Insect Control, Pacific Islands
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.